Colorectal News and Research

RSS

Physical symptoms such as nausea and shortness of breath, may predict shorter survival for patients with terminal cancer

A new study published July 26, 2004 in the online edition of CANCER, a peer-reviewed journal of the American Cancer Society, finds a patient's symptoms and results of quality of life assessments may provide important clues to an individual patient's prognosis. Psychosocial factors, such as anxiety or spiritual distress, did not predict shorter survival.

26 Jul 2004

Cancers of the gut amongst the most preventable through changes in diet

Cancers of the gut are one of the major causes of death from cancer, but a review published this week shows that they are also amongst the most preventable through changes in diet.

23 Jul 2004

ImClone quarterly sales reach $71.4 Million

Total revenues for the second quarter of 2004 were $71.5 million as compared with $17.9 million for the second quarter of 2003 and $109.6 million in the first quarter of 2004.

22 Jul 2004

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Erbitux (cetuximab), offers another option for patients who have colorectal cancer that resists standard chemotherapy treatment, according to an article written by two Mayo Clinic cancer researchers published in the current edition of the New England Journal of Medicine.

21 Jul 2004

Chemotherapy and supportive care are a winning combination

Gastrointestinal cancer, including colorectal, is one of the most common groups of cancers to claim Western lives.

21 Jul 2004

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

CancerVax Corporation has announced that its wholly owned subsidiaries, Tarcanta, Inc., and Tarcanta, Ltd. (Ireland), have obtained the exclusive rights to complete the clinical development of three specific active immunotherapeutic (SAI) product candidates that target the epidermal growth factor receptor (EGFR) signaling pathway for the treatment of cancer.

19 Jul 2004

Evidence that new anti-inflammatory drug may sensitize leukemia, and breast and lung cancers to conventional chemotherapy

Ohio researchers have used a recently developed anti-inflammatory drug as a starting point to construct a possible new, targeted anti-cancer agent.

10 Jul 2004

Drinking lots of milk may lower the risk of colorectal cancer

Drinking lots of milk and increasing your calcium intake may lower the risk of colorectal cancer, according to a new study that appears in the July 7 issue of the Journal of the National Cancer Institute.

7 Jul 2004

Four most common cancers accounted for over half of the 225,000 new cases of malignant cancer registered in England in 2001

The four most common cancers - breast, lung, colorectal and prostate - accounted for over half of the 225,000 new cases of malignant cancer (excluding non-melanoma skin cancer) registered in England in 2001.

30 Jun 2004

There are 9.8 million cancer survivors in the United States

A cancer survivor is defined as anyone who has been diagnosed with cancer, from the time of diagnosis through the balance of his or her life. The findings are published in the June 25 issue of CDC's Morbidity and Mortality Weekly Report, "Cancer Survivorship - United States, 1971 - 2001."

24 Jun 2004

Joint initiative to tackle cancer, diabetes, heart disease and stroke

Three of the nation’s leading not-for-profit health agencies today announced a joint initiative to empower Americans to help lower their risk of cancer, diabetes, heart disease and stroke by following a single set of recommendations.

16 Jun 2004

Calcium supplements can decrease the risk of all types of colorectal polyps

While taking calcium supplements can decrease the risk of all types of colorectal polyps, research led by Dartmouth Medical School shows calcium had the greatest effect on advanced colorectal adenomas, considered to be most strongly associated with invasive colorectal cancer.

15 Jun 2004

Racial and ethnic minorities, women, and the elderly were less likely to enroll in cancer clinical trials than whites, men, and younger patients

According to background information provided by the authors, "Ten years have passed since Congress responded to concerns about unequal access to clinical trials and enacted the National Institutes of Health (NIH) Revitalization Act, which encouraged representation of women and minority patients in NIH-sponsored research.

14 Jun 2004

Drug Tarceva improves survival chance for patients with advanced lung cancer

Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).

5 Jun 2004

Diabetics could be up to three times more likely to get bowel cancer

People with diabetes could be up to three times more likely to get bowel cancer – according to a report from Cancer Research UK and the Medical Research Council published*(1) today.

5 Jun 2004

People with diabetes could be up to three times more likely to get bowel cancer

Scientists tested a marker of the sugar levels in blood samples*(2) taken from almost 10,000 men and women aged between 45-79 and then checked their medical condition six years later.

5 Jun 2004

Drug helps patients with metastatic colorectal cancer

A drug designed to cut off a tumor’s blood supply, when paired with a chemotherapy combination, resulted in significant improvement in survival in patients with metastatic colorectal cancer, the first time in decades that survival times have been extended in patients with this devastating form of advanced cancer.

3 Jun 2004

Drug to extend lives of colorectal cancer patients

A drug designed to cut off a tumor's blood supply, when paired with a chemotherapy combination, resulted in significant improvement in survival in patients with metastatic colorectal cancer, the first time in decades that survival times have been extended in patients with this devastating form of advanced cancer.

2 Jun 2004

Avastin study shows significant improvement in patients with metastatic colorectal cancer

Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.

2 Jun 2004

Study may help oncologists tailor chemotherapy to patients based on their genetic make-up

Genetic variations in an individual’s ability to repair DNA damage may help predict survival in lung cancer patients treated with the common chemotherapy drugs cisplatin or carboplatin, a new study shows.

2 Jun 2004

Colorectal News and Research

Physical symptoms such as nausea and shortness of breath, may predict shorter survival for patients with terminal cancer

Cancers of the gut amongst the most preventable through changes in diet

ImClone quarterly sales reach $71.4 Million

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Chemotherapy and supportive care are a winning combination

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

Evidence that new anti-inflammatory drug may sensitize leukemia, and breast and lung cancers to conventional chemotherapy

Drinking lots of milk may lower the risk of colorectal cancer

Four most common cancers accounted for over half of the 225,000 new cases of malignant cancer registered in England in 2001

There are 9.8 million cancer survivors in the United States

Joint initiative to tackle cancer, diabetes, heart disease and stroke

Calcium supplements can decrease the risk of all types of colorectal polyps

Racial and ethnic minorities, women, and the elderly were less likely to enroll in cancer clinical trials than whites, men, and younger patients

Drug Tarceva improves survival chance for patients with advanced lung cancer

Diabetics could be up to three times more likely to get bowel cancer

People with diabetes could be up to three times more likely to get bowel cancer

Drug helps patients with metastatic colorectal cancer

Drug to extend lives of colorectal cancer patients

Avastin study shows significant improvement in patients with metastatic colorectal cancer

Study may help oncologists tailor chemotherapy to patients based on their genetic make-up

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News